ReportWire

Tag: Government policy

  • FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases

    FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases

    [ad_1]

    A Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided midyear for a fall campaign, the Associated Press reported. 

    “This is a consequential meeting to determine if we’ve reached the point in the pandemic that allows for simplifying the use of current COVID-19 vaccines,” said the FDA’s Dr. David Kaslow.

    The panel agreed that people should get the same vaccine formula whether they’re receiving their initial vaccinations or a booster. Today, Americans get one formula based on the original coronavirus strain that emerged in 2020 for their first two or three doses, and their latest booster is a combination shot made by Pfizer
    PFE,
    -0.33%

    or Moderna
    MRNA,
    -0.90%

    that adds protection against omicron.

    The FDA would have to decide how to phase in that change.

    COVID-19 vaccines have saved millions of lives, and booster doses remain the best protection against severe disease and death. But Americans are tired of getting vaccinated. While more than 80% of the U.S. population has had at least one COVID-19 shot, only 16% of those eligible for the latest boosters — so-called bivalent doses updated to better match more recent virus strains — have gotten one.

    Separately, the Centers for Disease Control and Prevention offered an update Friday on the strains that are dominant in the U.S., showing that XBB.1.5, the omicron sublineage that first emerged in small numbers in October, has extended its lead over other variants.

    XBB.1.5 accounted for 61.3% of cases in the week through Jan. 28, the data shows, up from 49.1% a week ago. The prior dominant variants, BQ.1.1 and BQ.1, together accounted for 31.1% of new cases.

    In the CDC’s Region 2, which includes New York, New Jersey, the U.S. Virgin Islands and Puerto Rico, XBB.1.5 accounted for 91.1% of new cases, up from 86.8% the previous week.

    The World Health Organization said this week that it now has data on XBB.1.5 from 54 countries, showing it has a growth advantage over other circulating strains but still appears no more severe.

    In its weekly epidemiological update, the agency said it has raised the confidence level of its risk assessment for XBB.1.5 to “moderate” from “low,” using these additional reports. The highest number of XBB.1.5 cases are showing up in the U.S., the U.K., Canada, Denmark, Germany, Ireland and Austria.

    The news comes as the seven-day average of new cases stood at 46,300 on Thursday, according to a New York Times tracker. That’s down 24% from two weeks ago. The daily average for hospitalizations was down 24%, at 34,833. The average number of deaths was 549, down 3% from two weeks ago. 

    Cases are currently climbing in eight states — Illinois, Tennessee, Minnesota, Alaska, South Dakota, Vermont, Kentucky and Kansas — as well as in the U.S. Virgin Islands and Washington, D.C.

    Coronavirus update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • China’s claim that COVID cases and deaths have peaked and are falling fast is failing to take on board that testing is not keeping up with infections, the Guardian reported. China ended its zero-COVID policy in December and promptly saw a wave of cases spread across the nation. Its health authorities said this week that the worst is behind it, but experts are wary that it is underreporting numbers, as it has since the start of the pandemic. Now the pullback in testing is a factor, according to the Guardian. Daily tests had dropped to 280,000 by Monday, down from 150 million on Dec. 9, and 7.54 million on Jan. 1. Some provinces had enacted systems for collecting the results of residents or allowing residents to self-report, but the figures were “affected by the willingness of residents to test.”

    What’s seen as the world’s largest annual human migration is under way again in China for the Lunar New Year, after the country lifted pandemic restrictions. WSJ’s Yoko Kubota reports on how it’s expected to boost the economy–and the risk of new Covid-19 outbreaks. Photo: Cfoto/Zuma Press

    • South Korea says it will continue to restrict the entry of short-term travelers from China through the end of February over concerns that the spread of COVID may worsen following the Lunar New Year holidays, the AP reported. South Korea in early January stopped issuing most short-term visas at its consulates in China, citing concerns about the virus surge in the country.

    • Spain is set to end the mandatory use of face masks on public transport nearly three years after the start of the pandemic, the AP reported separately. Spanish Health Minister Carolina Darias said Thursday she would recommend that the government remove the health regulation when the cabinet meets on Feb. 7. Face masks will remain obligatory inside hospitals, health clinics, dentist offices and pharmacies.

    Here’s what the numbers say:

    The global tally of confirmed COVID-19 cases topped 669.9 million Wednesday, while the death toll rose above 6.82 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 102.3 million cases and 1,107,559 fatalities.

    The CDC’s tracker shows that 229.6 million people living in the U.S., equal to 69.2% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 51.4 million Americans, equal to 15.5% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • Bed Bath & Beyond stock plunges more than 20% after filing shows default on loans

    Bed Bath & Beyond stock plunges more than 20% after filing shows default on loans

    [ad_1]

    Bed Bath & Beyond Inc. shares plunged more than 20% and were halted Thursday afternoon, after the retailer disclosed in a filing that it was in default on loans that have been called in.

    The struggling retailer finally filed its quarterly report with the U.S. Securities and Exchange Commission on Thursday at roughly 2:30 p.m. Eastern time, after being threatened with having its stock delisted for being late with the required report.

    Included in the filing is news that Bed Bath & Beyond
    BBBY,
    -22.22%

    had defaulted on loans earlier this month, and executives were informed on Wednesday by banker JP Morgan Chase & Co.
    JPM,
    +0.62%

    that the debt was due immediately.

    “On or around January 13, 2023, certain events of default were triggered under the Company’s Credit Facilities as a result of the Company’s failure to prepay an overadvance and satisfy a financial covenant, among other things,” the filing reads.

    “As a result of the continuance of such events of default, on January 25, 2023, the administrative agent under the Amended Credit Agreement notified the Company that (i) the principal amount of all outstanding loans under the Credit Facilities, together with accrued interest thereon, the FILO Applicable Premium and all fees (including, for the avoidance of doubt, any break funding payments) and other obligations of the Company accrued under the Amended Credit Agreement, are due and payable immediately.”

    See also: Bed Bath & Beyond bankruptcy warning marks latest chapter in troubled retailer’s downward spiral

    Shares had traded between $3.25 and $3.47 on the day until about 5 minutes after the filing was released, when shares suddenly dove, triggering a halt. The stock fell as low as $2.10 and was halted three times between 2:46 p.m. and 3:14 p.m. before closing at $2.52, a 22.2% daily decline.

    The struggling retailer admitted earlier this year that it has “substantial doubt” about its “ability to continue as a going concern” and may need to declare bankruptcy. The home goods retailer also said that it expects to record lower sales for the latest quarter than analysts were anticipating.

    “As we consider all paths and strategic alternatives, we continue to work with our advisors and implement actions to manage our business as efficiently as possible,” a Bed Bath & Beyond spokesperson said in an email Thursday. “As is our practice, we do not comment on speculation. We will update all stakeholders on our plans as they develop and finalize.”

    Bed Bath & Beyond stock has become popular with “meme” traders and short sellers, who have been betting on opposite sides of the trade as the retailer reported a poor holiday season and plans to shut down stores. Shares have traded as high as $30.06 and as low as $1.27 in the past 12 months, while declining 81.8% overall in that time. The S&P 500 index
    SPX,
    +1.10%

    has declined 7.7% in the past 12 months.

    See also: Why naked short selling has suddenly become a hot topic

    [ad_2]

    Source link

  • China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is past

    China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is past

    [ad_1]

    A few days into the first Lunar New Year holiday since the lifting of pandemic restrictions in China, Chinese consumers are eager to travel but are also wary as a major COVID wave sweeps the nation, MarketWatch’s Tanner Brown reported.

    The 15-day festival is considered the world’s largest annual migration, during which students and workers return to their hometowns in droves — that is, until COVID shut down travel in 2020.

    On…

    [ad_2]

    Source link

  • FDA backs annual COVID vaccine for Americans with strain to be decided midyear

    FDA backs annual COVID vaccine for Americans with strain to be decided midyear

    [ad_1]

    The Food and Drug Administration is recommending that the U.S. decide each June which SARS-CoV-2 strains should be included in an annual fall booster shot.

    Doing so would allow updated COVID-19 vaccines to be ready for distribution “no later than September” each year, according to documents published by the regulator.

    The FDA’s Vaccines…

    [ad_2]

    Source link

  • Feds poised to file another antitrust suit against Google this week: report

    Feds poised to file another antitrust suit against Google this week: report

    [ad_1]

    The U.S. Justice Department is preparing to sue Alphabet Inc. in the coming days over its dominance in the online ad market, according to a report late Monday.

    Citing sources familiar with the matter, Bloomberg News reported the antitrust suit is expected to be filed in federal court before the end of this week, and as soon as Tuesday.

    The pending filing has been rumored for months, after the Justice Department reportedly rejected concessions offered by Google last summer. A Google spokesperson declined to comment Monday.

    Google dominates the online ad market, earning more than one-quarter of U.S. digital-advertising revenue, according to estimates from research firm Insider Intelligence Inc.

    It would be the second antitrust suit filed by the Justice Department against Google parent Alphabet. In October 2020, the DOJ accused Google of being “a monopolist in the general search services, search advertising, and general search text advertising markets.” In a 2020 blog post, Google called that suit “deeply flawed” and said people use Google because they choose to, not because they are forced to. That case is set for trial in the fall.

    Alphabet faces a number of other lawsuits targeting its business practices, including a $16.3 billion class-action suit filed in the U.K. in November accusing the tech giant of reaping “super profits” at the expense of thousands of smaller companies. Google called that lawsuit “speculative and opportunistic.”

    Alphabet’s Class A shares
    GOOGL,
    +1.81%

    are down 24% over the past 12 months while its Class C shares
    GOOG,
    +1.94%

    have fallen about 22%, compared to the S&P 500’s
    SPX,
    +1.19%

    9% dip over the past year. Both classes of Alphabet shares dipped nearly 1% in after-hours trading Monday after the Bloomberg report was published.

    [ad_2]

    Source link

  • Genius Group CEO on why his company is fighting back against naked short sellers — and it’s not alone

    Genius Group CEO on why his company is fighting back against naked short sellers — and it’s not alone

    [ad_1]

    “It’s like being robbed in a library, but you can’t shout ‘Thief!’ because there are ‘Silence, please’ signs everywhere.”

    That’s how Roger Hamilton, chief executive of Genius Group Ltd.
    GNS,
    +55.02%
    ,
    describes the powerlessness he feels as U.S. securities rules prevent him from discussing his company’s share price, even as it comes under attack from a group of naked short sellers.

    The Singapore-based education company on Thursday announced it had appointed a former FBI director to lead a task force investigating alleged illegal trading in its stock that it first addressed in early January. 

    For context: Genius Group stock rallies more than 200% after it appoints former F.B.I. director to investigate alleged naked short selling

    The news sent the stock up a record 290% on Thursday, and it climbed another 59% on Friday. Volume of about 270 million shares traded in Thursday’s session crushed the daily average of about 634,000 — another indicator, Hamilton told MarketWatch in an interview Friday, of wrongdoing, given that the company’s float is just 10.9 million shares. “Clearly, that’s far more shares than we created,” he said.

    Genius Group has evidence from Warshaw Burstein LLP and Christian Levine Law Group, with tracking from Share Intel, that certain individuals and/or companies sold but failed to deliver a “significant” amount of its shares as part of a scheme seeking to artificially depress the stock price.

    The company is now exploring legal action and is planning an extraordinary general meeting in the coming weeks to get shareholder approval for its planned actions. These include paying a special dividend as a way to flush out bad actors and working with regulators to share information.

    Share Intel uses tracking software in real time to determine exactly where there are discrepancies in the market and where brokers are opening large positions, Hamilton said. The software can measure the number of shares that are being naked shorted and has found multiple instances where significant amounts of fake shares were being created, said Hamilton.

    Naked short selling is illegal under Securities and Exchange Commission rules, but that hasn’t stopped the practice, which Hamilton said affects far more companies than is generally known.

    In regular short trading, an investor borrows shares from someone else, then sells them and waits for the stock price to fall. When that happens the shares are bought cheaper and returned to the prior owner, with the short seller pocketing the difference as profit.

    In naked short selling, investors don’t bother borrowing the stock first and simply sell shares with a promise to deliver them at a later date. When that promise is not fulfilled, it’s known as failure to deliver.

    By repeating that process again and again, bad actors can generate massive profits and manipulate a stock’s price lower, with an ultimate goal of driving a company to bankruptcy, at which point all the equity is wiped out and the naked shorts no longer need to be covered.

    Hamilton said the evidence gathered by Genius Group shows a great deal of the illegal activity is happening on U.S. exchanges, but there’s also activity happening off-exchange and involving dark pools.

    The company is fighting back “because we want this to stop,” Hamilton told MarketWatch. “They’re taking value away from our shareholders. They’re predators. They’re doing something illegal, and we want it to stop, whether that means getting regulators to enforce existing regulations or put new ones in place.”

    Public companies have to have committees to monitor and report internal fraud to protect shareholders, he said. But there is no such team looking for external fraud and many retail investors see stocks being manipulated, he said.

    “Hopefully, regulations will change and regulators will see there are as many, if not more, threats from outside a company,” he said.

    Genius Group is not alone, said Hamilton. He cited among other examples Torchlight, an oil- and gas-exploration company that decided to merge with Metamaterial Inc. to thwart a naked-short-selling attack.

    The stock rose from 30 cents to $11 in the six months after the deal was completed, and the company was able to raise about $183 million through a combination of convertible debt and equity. An interview Hamilton conducted with Torchlight’s former CEO, John Brda, can be found below.

    Then there’s Jeremy Frommer, CEO of Creatd Inc.
    CRTD,
    +4.14%
    ,
    which aims to unlock creativity for creators, brands and consumers, who is behind Ceobloc, a website that aims to end the practice of naked short selling.

    “Illegal naked short selling is the biggest risk to the health of today’s public markets,” is how the site introduces its mission.

    On Friday, the stock of Helbiz Inc.
    HLBZ,
    +65.48%

    joined Genius Group in rocketing higher in high volume, after that company said it, too, was taking on naked short sellers.

    The New York–based maker of e-scooters and e-bicyles said that it was following Genius Group’s example and that it believes “certain individuals and/or companies may have engaged in illegal short selling practices that have artificially depressed the stock price.” The stock had plummeted 64% over the three months through Thursday’s close at 12.31 cents.

    Genius Group’s stock, which went public in April 2022 at $6 a share, has gained more than 600% this week. The S&P 500
    SPX,
    +1.89%

    has gained 1.1% over the same four trading sessions.

    [ad_2]

    Source link

  • Omicron subvariant gains more ground in U.S. to account for 49.1% of new COVID cases, CDC data show

    Omicron subvariant gains more ground in U.S. to account for 49.1% of new COVID cases, CDC data show

    [ad_1]

    The XBB.1.5 omicron subvariant that became dominant in the U.S. last week has gained more ground, according to data from the nation’s main health agency, accounting for 49.1% of new cases in the latest week, up from 43% a week ago.

    The subvariant is pulling further ahead of BQ.1.1 and BQ.1, the former dominant strains of the coronavirus that causes COVID, according to the data from the Centers for Disease Control and Prevention.

    BQ.1.1 accounted for 26.9% of new cases, down from 28.8% a week ago, while BQ.1 accounted for 13.3%, down from 15.9% a week ago.

    In the New York region, which includes New Jersey, Puerto Rico and the U.S. Virgin Islands, XBB.1.5 accounted for 86.8% of new cases, up from 82.7% a week ago.

    The World Health Organization has acknowledged that XBB.1.5, which was first detected in tiny numbers in the U.S. in October, has become the most transmissible variant yet thanks to a growth advantage. The agency said that it appears to have a greater ability to evade immunity than earlier variants.

    In its weekly epidemiological update, the agency said the XBB line is one of four omicron subvariants that are showing transmission advantage over other circulating variants. The other three are BF.7, BQ.1 and BA.2.75.

    For now, the WHO said it has no additional data on XBB.1.5, but BA.2.75.2 is showing the most neutralization resistance to sera from vaccinated and COVID-infected patients.

    In the U.S., the seven-day average of new COVID cases stood at 50,839 on Thursday, according to a New York Times tracker. That’s down 20% from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    The daily average for hospitalizations was down 18% at 39,272. The average for deaths was 498, up 5% from two weeks ago. 

    Cases are rising in just six states, as well as the U.S. Virgin Islands, Washington, D.C., and Puerto Rico, a significant improvement from recent trends. On a per capita basis, Illinois now has the most cases at 31 per 100,000 residents, followed by Kentucky at 30 and Rhode Island at 27.

    See also: Americans are facing years of ‘tripledemic’ winters that may put patients with other ailments at risk, Jha says

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Japanese Prime Minister Fumio Kishida on Friday announced plans to downgrade the legal status of COVID-19 to the equivalent of seasonal influenza in the spring, a move that would further relax mask requirements and other preventive measures as the country seeks to return to normalcy, the Associated Press reported. Kishida said he has instructed experts and government officials to discuss the details on changing the status of COVID-19. A change would also remove self-isolation rules and other antivirus requirements and allow COVID-19 patients to seek treatment at any hospital instead of restricting them to specialized facilities.

    Read also: Moderna is the latest company to produce a promising RSV vaccine

    • As Chinese people crowd onto trains and buses ahead of the Lunar New Year holiday, which begins on Jan. 21, officials are playing down fears that widespread travel over the popular family holiday will lead to a spreader event, Reuters reported. In comments reported by state media late Thursday, Vice Premier Sun Chunlan said the virus was at a “relatively low” level, while health officials said the number of COVID patients in the hospital and in critical condition was on the decline. But there are doubts about China’s official account of an outbreak that has overwhelmed hospitals and funeral homes since Beijing abandoned strict COVID controls and mass testing last month.

    What’s seen as the world’s largest annual human migration is under way again in China for the Lunar New Year after the country lifted pandemic restrictions. The Wall Street Journal’s Yoko Kubota reports on how it’s expected to boost the economy — and the risk of new COVID-19 outbreaks. Photo: Cfoto/Zuma Press

    • CureVac’s
    CVAC,
    +1.06%

    promising Phase 1 data for flu and COVID-19 vaccine candidates is a signal to investors that its messenger RNA technology is competitive, according to UBS Securities analysts, who upgraded the company’s stock to buy from neutral on Thursday, as MarketWatch’s Jaimy Lee reported. They also more than doubled the price target, to $18 from $8. CureVac had attempted to develop a first-generation COVID vaccine but failed. “As the first data of the 2nd-gen platform’s immunogenicity in humans, this is a major inflection point for the story, and suggests potentially competitive mRNA platform relative to mRNA peers,” the analysts wrote.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 668.3 million on Thursday, while the death toll rose above 6.73 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.9 million cases and 1,103,681 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.5 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 50.7 million Americans, equal to 15.3% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • Bed Bath & Beyond gets Nasdaq delisting warning, stock tumbles 7%

    Bed Bath & Beyond gets Nasdaq delisting warning, stock tumbles 7%

    [ad_1]

    Bed Bath & Beyond Inc. has received a warning that it is not in compliance for continued Nasdaq listing because the company has not yet filed its Form 10-Q quarterly report with the Securities and Exchange Commission.

    In an SEC filing Thursday, the troubled home-goods retailer said it had received the Nasdaq notice on Jan. 12. The notice has no immediate effect on the listing or trading of Bed Bath & Beyond’s
    BBBY,
    -4.09%

    common stock on the Nasdaq
    COMP,
    +0.86%
    ,
    the filing said. “The Notice states that the Company has 60 calendar days from the date of the Notice, or March 13, 2023, to submit a plan to regain compliance with the Listing Rule,” Bed Bath & Beyond said in the filing.

    [ad_2]

    Source link

  • Genius Group stock rallies more than 200% after it appoints former F.B.I. director to investigate alleged naked short selling

    Genius Group stock rallies more than 200% after it appoints former F.B.I. director to investigate alleged naked short selling

    [ad_1]

    The stock of a Singapore-based ed-tech and education company called Genius Group Ltd. rallied more than 200% on Thursday, after it said it appointed a former F.B.I. director to lead a task force investigating alleged illegal trading in its stock that it first disclosed in early January. 

    The stock was last up 264% to mark its biggest-ever one-day percentage gain. Volume of 197.76 million shares traded crushed the 65-day average of just 634,17. Genius Group
    GNS,
    +290.29%

    also said it would issue a special dividend to shareholders to help expose the wrongdoing and is considering a dual listing that would make illegal naked short selling more difficult.

     The task force will be led by Timothy Murphy, a former deputy director of the F.B.I. who is also on the board. It will include Richard Berman, also a Genius Group Director and chair of the company’s Audit Committee, and Roger Hamilton, the chief executive officer of Genius Group.

    “The company has been in communication with government regulatory authorities and is sharing information with these authorities to assist them,” the company said in a statement.

    Genius Group said it has proof from Warshaw Burstein LLP and Christian Levine Law Group, with tracking from Share Intel, that certain individual and/or companies sold but failed to deliver a “significant” amount of its shares as part of a scheme seeking to artificially depress the stock price.

    It will now explore legal action and will hold an extraordinary general meeting in the coming weeks to get shareholder approval for its planned actions.

    On the Genius website, Hamilton explains what the company, which went public in 2022, thinks happened.

    Genius’ IPO priced at $6 a share in April of 2022, he wrote in a blog. The company, which aims to develop an entrepreneur education system, then completed five acquisitions of education companies to build out its portfolio and reported more than 60% growth in its last earnings report.

    Analysts at Diamond Equity assigned it an $11.28 stock price target, while Zacks assigned it a $19.20 stock price target.

    “By all measures, we believed we were doing all the right things to justify a rising share price,” said Hamilton.

    The company then announced two funding rounds totaling $40 million to grow its balance sheet to more than $60 million, yet its stock fell to under 40 cents, or less than 25% of the cash raised and less than 20% of its net assets.

    “This didn’t happen gradually,” the executive wrote. “It happened in two month intervals from our IPO, in June, August, October and December. Each time, over a period of a few days, massive selling volume that was a multiple of our float (As most of our shares are on lock up, only around 4 million are tradeable) was sold into the market, making our share price drop by 50% or more.”

    The company has since drawn on Wes Christian, a short-selling litigator from Christian Levine Law Group, who has helped it understand how naked short selling works, and then Share Intel helped find the proof that that’s what has happened.

    Individuals or groups get together and sell shares in a target company that they don’t own, with the aim of getting the share price to fall 50% in a short period. They use small-cap firms that have low buying volume, allowing them to scare off buyers.

    “The broker doesn’t bother to find shares to borrow,” said Hamilton. “They simply sell shares they don’t have and after a few days book them as FTDs (failure to deliver) or hide them as long sales instead of short sales. The people who bought the shares have no idea they bought a fake share, and suddenly there’s plenty more shares in the market than there should be.”

    If these groups sell 6 million shares from $12 to $6 each, and then buy back over two months at under $6, they double their money. That allows them to make up to $30 million out of thin air. They can then repeat the whole process a few months later.

     “If they don’t buy back all the shares, they simply leave them as FTDs or hide them in offshore accounts,” he wrote. “At no point do they need to put up any cash to make this happen, as they’re making money from the moment they start selling fake shares.”

    The ultimate goal is to push a company into bankruptcy, where the equity will be wiped out, meaning they never have to cover the short position on the fake shares.

    By issuing a special dividend, Genius is hoping to find who is responsible, as all brokers are forced to disclose to the Depository Trust & Clearing Corp. (DTCC) how many shares their clients hold and how many dividends will be paid. Theoretically, that should expose the oversold shares and dishonest brokers will be forced to cover their position, said Hamilton.

    In practice, dishonest brokers will not declare the fake shares and just pay the dividend out of their own pockets.

    “If you issue a dividend that isn’t straight cash—such as a spinoff of a company so you are issuing shares, or a blockchain based asset, then the brokers can’t do that are a forced to either cover or be exposed,” he wrote.

    [ad_2]

    Source link

  • Why the U.S. debt-ceiling is worrying stock and bond investors

    Why the U.S. debt-ceiling is worrying stock and bond investors

    [ad_1]

    The U.S. Treasury Department began taking “extraordinary measures” on Thursday to keep the federal government current on its bills, while giving Congress more time to come up with a debt ceiling deal.

    Those special measures allow the Treasury to keep paying its bills, including paying holders of government debt what they are due, while also, for now, continuing the issuance of bills and notes as scheduled in the near $24 trillion Treasury market, the world’s biggest debt market, to replace maturing debt.

    “There’s constant maturities and constant new issuance,” said Jim Vogel, an interest-rate strategist at FHN Financial, in an interview Thursday. “Until the Treasury calls a halt to auctions they go on as normal.”

    In part, new note auctions on deck will replace maturing bonds issued years ago, which should help give confidence to investors that the U.S. government intends to fully repay principal and interest, as promised. It also helps bide time for Congress to strike a deal to increase or suspend the existing debt limit.

    “Your early warning system is when 6-month bills get cheaper,” Vogel said, adding that a wobble in that part of the Treasury market could signal worries by investors that top lawmakers could fail to reach a debt ceiling deal by this summer, which could then raise the threat level of a U.S. government default.

    What’s next in the U.S. debt limit standoff

    The U.S. debt limit was first set in 1917, and already has been increased or suspended 102 times since World War II, according to David Kelly, chief global strategist at JP Morgan Funds, in a recent client note.

    The government had been approaching its current debt limit of $31.385 trillion, prompting Treasury Secretary Janet Yellen on Thursday to deploy special measures to keep the government current on its bills, including making payments to bondholders, in moves she outlined a week ago.

    Kelly said the Treasury has leeway to make adjustments to postpone “our real rendezvous with disaster” potentially until June, but that from an economic and financial perspective a U.S. default would be “an unmitigated disaster.”

    Tax payments due to the U.S. government from corporations and households this spring also factor into the bigger debt-limit picture, while also influencing the final deadline for Congress to avoid an default on America’s debt.

    “We are coming up to the March corporate tax day,” said Steven Ricchiuto, U.S. chief economist at Mizuho Securities, by phone Thursday. “That could boost the Treasury’s balances,” he said, while also noting the influx from taxes last was higher than anticipated.

    Why investors are focusing on the debt ceiling now

    With the ultimate showdown likely months away there are no discernible ripples in financial markets right now, but investors and analysts do seem to be paying much closer attention to the threat at a much earlier date than in past episodes, market watchers said.

    Blame the intraparty battle between House Republicans that saw Kevin McCarthy elected speaker on Jan. 7 after a historic 15 ballots – and only after agreeing to a series of concessions to a small group of far-right conservatives.

    Investors are “talking about it early because it came on the heels of a very difficult election of the speaker of the House and the sense that there’s now much more leverage that a few members of Congress may have to force this crisis that’s more likely to hit later in the summer,” said Christopher Smart, chief global strategist at Barings and head of the Barings Investment Institute, in a phone interview.

    Some recent history underscores the concern. It took all of then-Speaker John Boehner’s political capital – “and then some” – to finally secure a vote among the Republican caucus on raising the debt limit during a similar showdown in 2011, Smart noted, observing that Boehner had “much more leeway” than McCarthy.

    “So if there are five or more members who won’t vote” on raising the limit “without certain conditions being met,” it’s easy to imagine potentially ugly scenarios that could rattle markets, he said.

    What’s at stake

    Former Federal Reserve Bank of New York President Bill Dudley said Thursday in an interview with Bloomberg that a U.S. default would be a “huge blow” to markets, but also that a contingency plan exits if it happens.

    “The way it works is if you actually run out of money, the Treasury will decide what payments to present to the Fed,” Dudley said. “Presumably, the Treasury will decide to prioritize debt repayment and interest payments, so there isn’t a technical default. The Fed will basically honor the payments the Treasury present.”

    The Fed also could step in to shore up market functioning in the Treasury market, if needed.

    “What we saw in 2011 is that the Treasury market got stronger until we got close to the deadline,” Dudley said. “People don’t want to buy Treasury bills that are maturing right around the time the debt limit could be binding.”

    As a result of a 2011 debt-ceiling standoff, credit rating firm Standard & Poor’s downgraded the U.S. credit ratings to AA from AAA.

    U.S. stocks declined for a third straight day on Thursday, with the Dow Jones Industrial Average
    DJIA,
    -0.76%

    losing 252.40 points, or 0.8%, while the S&P 500
    SPX,
    -0.76%

    shed 0.8% and the Nasdaq Composite Index
    COMP,
    -0.96%

    dropped 1%.

    —Greg Robb contributed reporting to this article.

    [ad_2]

    Source link

  • Va. Senate Democrats kill effort to repeal electric car rule

    Va. Senate Democrats kill effort to repeal electric car rule

    [ad_1]

    RICHMOND, Va. — Virginia Senate Democrats on Tuesday defeated several Republican efforts to repeal a so-called “clean cars” law that aims to reduce carbon pollution through the adoption of California’s stringent rules for vehicle emissions.

    The committee vote marked a critical juncture in the GOP repeal effort — one of this session’s highest-profile environmental debates. While there are still similar measures expected to advance through the Republican-controlled House, they would eventually land before the same Senate committee for a vote.

    Environmental groups, who say the adoption of the standards was one of the biggest steps Virginia has taken to address climate change, cheered Tuesday’s outcome.

    “The vote today shows that (Gov. Glenn) Youngkin-led attacks on Virginia’s bedrock climate laws are a dead end and that he should get on the side of making pollution progress and not stand against it,” said Walton Shepherd, Virginia policy director for the Natural Resources Defense Council.

    Republicans sought unsuccessfully last year to repeal the 2021 law, and Youngkin pledged to try again after California in August set itself on a path to require all new cars, pickup trucks and SUVs be electric or hydrogen by 2035. Under California’s standards, drivers can keep their existing gas-powered cars or buy used ones.

    Opponents of following California say its goals are unattainable and that the electric vehicles that will be required — and their batteries — are too expensive for many families. Speakers on Tuesday also raised concerns about whether the power grid would be able to handle the additional demand.

    Some Republican senators asked their colleagues to consider at least delaying implementation of the standards.

    “I hope that at least there’s a way we can amend this. Do something so that reasonable judgment can guide the day here,” Sen. Richard Stuart said.

    The Senate Agriculture, Conservation and Natural Resources Committee ultimately rolled several similar repeal bills together before voting the consolidated bunch down on an 8-7 party-line vote vote.

    The “clean cars” law was initially adopted two years ago, at a time when the state government was under full Democratic control. The measure that then-Gov. Ralph Northam signed into law was a top priority for environmental advocates at the time. It will require that starting in 2024 a certain percentage of new passenger vehicles sold by manufacturers be electric or hybrid electric.

    The mechanism for reaching the mandated vehicle sales threshold — which would start at roughly 8% in 2024 and then increase each year — involves adopting California’s vehicle emissions standards. California has had the authority to set its own rules for decades under a waiver from the federal Clean Air Act.

    The program applies to manufacturers, not car dealers. Manufacturers who aren’t in compliance can buy credits from others who have surpassed the target.

    Advocates of the change argued that some automakers prioritize sending their electric vehicles, or EVs, to states that use California’s standards. They said that has meant supply in Virginia isn’t meeting demand, especially outside of the Washington suburbs.

    The hope was that the law will make it easier and more likely that Virginians will choose cleaner cars and in turn help reduce pollution from the transportation sector, which federal data shows is Virginia’s single largest source of heat-trapping carbon dioxide.

    Opponents argued when the Virginia law was adopted that the commonwealth shouldn’t be tying its future to California.

    In August, after the California’s Air Resources Board further tightened its standards, state officials confirmed the change would apply to Virginia. Youngkin vowed to press for a repeal, saying he would work to “prevent this ridiculous edict from being forced on Virginians.”

    “As the governor stated, Democrats in Virginia outsourced the decision-making on energy policy to unelected bureaucrats in California,” Youngkin’s spokeswoman, Macaulay Porter, said in a statement.

    The governor has said he generally applauds efforts to move toward cleaner energy sources but thinks the methods adopted under previous years of Democratic control are too rigid.

    A representative for the Alliance for Automotive Innovation, which represents most automakers, said during the committee hearing that it was neutral on the bill. But the representative, Josh Fisher, raised concerns that Virginia had not enacted policies since 2021 to help support hitting the thresholds of the mandate.

    “I’m here to advocate for consumer purchase rebates, enhanced EV charging infrastructure build-out, updating your state building codes. These are all policies that you need to adopt if you’re going to move forward with this policy,” Fisher said.

    [ad_2]

    Source link

  • WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating

    WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating

    [ad_1]

    The World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people have succumbed to the virus since early December, the Associated Press reported. 

    The announcement of fatality numbers on Saturday came after weeks of complaints that China was not keeping experts abreast of what was happening.

    The announcement “allows for a better understanding of the epidemiological situation,” said a WHO statement. Director-general, Tedros Adhanom Ghebreyesus talked by phone with Health Minister Ma Xiaowei, it said.

    “WHO requested that this type of detailed information continued to be shared with us and the public,” the agency said.

    The National Health Commission said only deaths in hospitals were counted, which means anyone who died at home is not part of the tally. It gave no indication of when or whether it might release updated numbers. China has seen a wave of cases ever since the government ended stringent restrictions on movement in December.

    The WHO is now analyzing the data, which covers early December to Jan. 12. So far, the epidemiology is similar to what has been seen in other countries, “a rapid and intense wave of disease caused by known sub-variants of omicron with higher clinical impact on older people and those with underlying conditions,” said the statement.

     The agency is hoping to get more information on the exact variants that are circulating. China has reported that two omicron sublineages, dubbed BA.5.2 and BF.7 are spreading but the WHO needs more sequences to be shared with open databases to get fully up to date.

    See also: China reports first population drop in decades as birthrates plunge

    Tens of thousands of people resumed travels in and out of China on Sunday as the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Some travelers expressed relief to be reunited with their families. Photo: Tyrone Siu/Reuters

    In the U.S., the seven-day average of new U.S. COVID cases stood at 59,121 on Monday, according to a New York Times tracker. That’s flat from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    See also: Americans are facing years of ‘tripledemic’ winters that may put patients with other ailments at risk, Jha says

    The daily average for hospitalizations was down 8% at 45,052. The average for deaths stood at 562, up 78% from two weeks ago to continue the recent trend.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • The U.S. Centers for Disease Control and Prevention said its real-time surveillance system has met the statistical criteria to prompt additional investigation into whether there is a risk of ischemic stroke in people ages 65 and older who received the Pfizer/BioNTech
    PFE,
    -3.70%

    BNTX,
    -1.28%

    bivalent COVID vaccine. “Rapid-response investigation of the signal in the VSD (vaccine safety datalink) raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-42 following vaccination,” the agency said in a statement. No such signal has been identified with the Moderna
    MRNA,
    -0.68%

    bivalent vaccine, it added.

    • Italian tennis player Camila Giorgi has denied allegations that she obtained a false COVID-19 vaccine certificate to allow her to travel, the AP reported. A doctor is under investigation in Italy for supplying false certificates and fake vaccines and Giorgi’s name was revealed in a long list of people implicated by an Italian newspaper. Giorgi is currently competing in the Australian Open.

    Getting the flu can increase the risk of getting a second infection, including strep throat. WSJ’S Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang

    • The New York State Department of Health is “exploring its options” after a state Supreme Court judge struck down a statewide mandate requiring healthcare workers to be vaccinated against COVID-19, the AP reported separately. Judge Gerard Neri wrote in a ruling released Friday that Democratic Gov. Kathy Hochul and the health department overstepped their authority by mandating a vaccine that’s not included in state public health law, the Syracuse Post-Standard reported. The mandate is “null, void, and of no effect,” the judge said. He sided with Medical Professionals for Informed Consent, a group of medical workers impacted by the vaccination mandate.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 667.3 million on Tuesday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.7 million cases and 1,099,885 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.4 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 49.6 million Americans, equal to 15.9% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • Too Much Government Debt Could Become a Big Problem for the Stock Market

    Too Much Government Debt Could Become a Big Problem for the Stock Market

    [ad_1]

    It’s always fun until the bill comes due—and the bill always comes due. In fact, it’s coming due right about now.

    On Friday, Treasury Secretary Janet Yellen warned Congress that the U.S. would hit its debt ceiling this coming Thursday, earlier than many had expected. That doesn’t mean the government will be forced to stop paying its bills then—Yellen believes that the Treasury has enough cash and other ways to raise money to last it until early June—but it does mean that an issue that was still purely theoretical has become far more pressing as the X date approaches.

    [ad_2]

    Source link

  • New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says

    New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says

    [ad_1]

    The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers for Disease Control and Prevention early Friday.

    XBB.1.5 accounted for 43% of all COVID cases in the week through Jan. 14, pulling ahead of BQ.1.1, which accounted for 28.8% of new cases, and BQ.1, which accounted for 15.9%, the data showed.

    Last week, BQ.1.1 was still dominant nationwide, accounting for 33.5% of new cases versus XBB.1.5’s 30.4%.

    In the New York region, which includes New Jersey, the U.S. Virgin Islands and Puerto Rico, XBB.1.5 now accounts for 82.7% of new cases, up from 72.7% a week ago.

    On Thursday, the World Health Organization acknowledged that XBB.1.5, which was first detected in tiny numbers in the U.S. in October, has become the most transmissible variant yet thanks to a growth advantage, and said that it appears to have a greater ability to evade immunity than earlier variants.

    However, the immune-escape data is based on preliminary lab-based studies and not on research in humans. And with the only data to review coming from the U.S., the agency said there’s no information yet on clinical severity.

    XBB.1.5 is similar to its immediate predecessor XBB.1 but has an additional mutation to its spike protein that may be behind its growth advantage. For now, it does not appear to have any mutation that might lead to more severe disease or death, WHO officials have said. The agency is monitoring it along with five other omicron variants.

    On Friday, the WHO updated guidelines on face masks, treatments and patient care in the age of COVID, a reminder that the pandemic is not yet over, even if people are mostly behaving as if it is. Given current global trends, the agency is recommending that people wear face masks when in public settings that are enclosed or poorly ventilated. People who have been exposed to the virus should also wear masks.

    “Similar to previous recommendations, WHO advises that there are other instances when a mask may be suggested, based on a risk assessment,” the agency said in a statement. “Factors to consider include the local epidemiological trends or rising hospitalization levels, levels of vaccination coverage and immunity in the community, and the setting people find themselves in.”

    The WHO reduced its recommended isolation period for COVID patients and said they can end isolation early if they test negative on a rapid test. Patients with symptoms should isolate for 10 days from the start of symptom onset, but the agency has dropped its advice for an additional three days.

    For asymptomatic patients who test positive, the WHO now recommends five days of isolation, compared with 10 days previously.

    The WHO extended a strong recommendation for the use of Pfizer’s
    PFE,
    +0.29%

    antiviral Paxlovid for patients with mild to moderate symptoms who are at risk of hospitalization.

    The data comes as the seven-day average of new U.S. cases stood at 60,610 on Thursday, according to a New York Times tracker. That’s up 4% from two weeks ago and below the recent peak of 70,508 on Christmas Eve. The daily average for hospitalizations was up 10% to 45,842. The average for deaths was 564, up 61% from two weeks ago. 

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • The peak of China’s COVID-19 wave is expected to last two to three months and to soon extend over the country’s vast rural areas, where medical resources are relatively scarce, Reuters reported Friday, citing a Chinese epidemiologist. Infections are expected to surge in those areas as hundreds of millions of people travel to their hometowns for the Lunar New Year holiday, which starts Jan. 21. “Our priority focus has been on the large cities. It is time to focus on rural areas,” said Zeng Guang, the former chief epidemiologist at the Chinese Centers for Disease Control and Prevention, according to a report published in local media outlet Caixin on Thursday.

    • Private services offering Chinese travelers access to mRNA vaccines are attracting droves of mainlanders to Hong Kong and Macau, the Guardian reported on Friday, as people seek a booster shot that their government has refused to approve. The government only allowed its citizens to get homegrown vaccines developed by Sinopac and Sinopharm
    8156,
    +6.45%

    throughout the pandemic, but many people are now seeking the greater protection offered by the mRNA vaccines developed by Moderna
    MRNA,
    +2.10%

    and by Pfizer and German partner BioNTech
    BNTX,
    -2.92%
    .

    Tens of thousands of people have resumed travels in and out of China after the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Photo: Tyrone Siu/Reuters

    • Kansas Gov. Laura Kelly plans to return to work at the Statehouse Friday after learning that a COVID-19 test earlier in the week gave her a false positive result, her office said, the Associated Press reported. Kelly has been working in self-isolation at the governor’s residence since the false positive Tuesday. Her office announced that she had tested positive for COVID-19, and she postponed the annual State of the State address from Wednesday to Jan. 24.

    See also: Sick house: Florida man gets 8 ½ years for using COVID relief to buy lavish 12-acre estate, fleet of luxury cars

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 666.3 million on Friday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.6 million cases and 1,099,629 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.4 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 49.6 million Americans, equal to 15.9% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • The days of IRS forgiveness for RMD mistakes may soon be over

    The days of IRS forgiveness for RMD mistakes may soon be over

    [ad_1]

    Katie St. Ores has a 100% track record of getting her tax clients out of paying the steep penalty for missing a required minimum distribution from their retirement funds. That amounts to only two households getting forgiveness, but it represents a lot of dollars, because the fee for any sort of mistake with RMDs is 50% of what’s missing, which could be tens of thousands of dollars.   

    Now’s the time to make things right if you forgot to make your RMD payment by Dec. 31 for 2022, paid the wrong amount or realized you got it wrong in a past year. The faster you correct it, the more likely the IRS is likely to waive the fines — and your chances are good overall, despite the agency’s stern reputation. 

    Beware, though, that new rules are going into effect in 2023 that could make the IRS less accommodating. For one thing, the age to start RMDs is going to 73 this year, and then 75 in 2033, which means the government is going to be hungry for the missing revenue. Even more important, the penalty will be reduced to 25% — or 10% if you’re really quick about reporting it. 

    The IRS doesn’t publicly track how many people miss or make mistakes with their RMDs, but financial advisers and tax professionals say it happens often enough, and they consider the IRS to be quite liberal about granting waivers. 

    St. Ores, who is a financial adviser and tax preparer based in McMinnville, Ore., thinks the IRS has responded generously so far because they know the rules are complex and mistakes happen.

    “They know people are getting up there in age, and so they’ve probably said up to now, let’s just grant it,” says St. Ores. 

    But the new penalties seem worded to avoid waivers in the future, especially because of the extra reduction to 10% if you act to quickly correct mistakes. Up to now, the IRS has taken pains to point out how to ask for a forgiveness on its website, but now there will be new emphasis on the lower penalties. 

    “The 50% penalty effectively ‘scared’ taxpayers to withdraw RMDs, so reducing the penalty could reduce the fear of additional tax, leading to more taxpayers missing their RMDs,” says St. Ores. “Between more taxpayers that potentially neglect to take their RMDs because of a not-as-high penalty and confusion over the current required age, the IRS will probably collect more taxes overall.”

    What to do about past mistakes

    There are a lot of different ways to mess up your required minimum distributions. The amount you’re supposed to pay is calculated according to a formula that takes your account balance of all your qualified tax-deferred accounts and multiplies it by a factor related to your age. 

    When you get started taking the money out, it works out generally to about 4% of the account value. You keep taking RMDs every year from your designated start time until the accounts are empty (or you die). The beginning age in the past was 70½, then it moved to 72, and now it’s changing to 73. 

    “These things can get complicated,” says Isaac Bradley, director of financial planning at Homrich Berg, an investment firm based in Atlanta. He advised one couple that accidentally took the distribution from the wrong spouse. 

    Another easy mistake is taking the wrong amount because of a math error. Sometimes, the problem is just about communication, because people tend to have multiple 401(k)s at old employers or several rollover IRAs that aren’t consolidated. The adviser helping make the calculations might not know of an account held at a different custodian, and that could throw off the whole equation.

    David Haas, a financial adviser and president of Cereus Financial Advisors, based in Franklin Lakes, N.J., has had to help family members correct RMDs, mostly having to do with inherited IRA accounts. 

    “You’re supposed to take RMD for the person who died, if they didn’t already take it,” he says, but a lot of people miss those in the confusion of grief. 

    Then once you inherit the account, you have to take RMDs over a 10 year period to empty the account. 

    “With one relative, she just kept on missing it and that was her fault. She didn’t realize what she was supposed to do. People don’t know the law, and it’s very confusing,” Haas says. 

    The first step is realizing you made a mistake, and then once you know that, pay the amount that’s missing. You need to file a special form with the IRS for the tax year in question (Form 5329), which you can send in at any point — you don’t have to wait until you file your next tax return. 

    If you want to ask for a waiver, you need to attach a letter explaining the mistake. If your request is not granted, then you pay the penalty.   

    While the process isn’t excessively complicated, you might want to consult with a tax professional to make sure you’re not making more mistakes in calculating the amount that’s missing. It could turn out to be a lot of paperwork if you have missed multiple years. 

    Kenneth Waltzer, a financial planner based in Los Angeles, had a client who did not realize he had inherited an IRA and missed the RMDs on it for five years. “He ignored emails about it,” says Waltzer. “When he came to us, it added up to over $100,000.” 

    For Katie St. Ores, the message going forward is going to be: Get it right the first time. Forgiveness may not be so easy to come by in the future. “I’m trying to stay on top of my clients taking their RMDs on time,” she says.  

    More from MarketWatch

    [ad_2]

    Source link

  • Genesis, Winklevoss twins’ Gemini crypto venture charged by SEC with selling unregistered securities

    Genesis, Winklevoss twins’ Gemini crypto venture charged by SEC with selling unregistered securities

    [ad_1]

    U.S. securities regulators on Thursday charged Genesis Global Capital and crypto exchange Gemini Trust Co. with offering and selling of unregistered securities to retail investors, bypassing disclosures and other requirements aimed at protecting market participants.

    Genesis and Gemini raised billions of dollars’ worth of crypto assets from hundreds of thousands of investors through unregistered offers, using a crypto asset-lending program called Gemini Earn, the Securities and Exchange Commission said.

    The complaint seeks the return of any “ill-gotten gains” plus interest, and any civil penalties, the SEC said.

    The SEC is also investigating whether other securities-law violations were committed and whether there are other companies or people relating to the alleged misconduct.

    Twins Tyler and Cameron Winklevoss are the founders of Gemini. The crypto exchange was sued late last year by investors alleging that the company sold interest-bearing accounts without registering them as securities, also through the Gemini Earn program.

    Also read: Gemini’s Cameron Winklevoss accuses crypto exec Barry Silbert of ‘bad faith’ stalling over frozen funds

    The Winklevoss twins were early champions of cryptocurrencies, using the money and fame they won in legal wrangling with Facebook parent Meta Platforms Inc.
    META,
    +2.87%

    and Meta’s founder Mark Zuckerberg over their role in creating the social-media giant to launch Gemini.

    According to the SEC complaint, the Gemini Earn agreement between Genesis, part of a subsidiary of Digital Currency Group, and Gemini started in December 2020.

    Gemini customers, including U.S. retail investors, were to have an opportunity to loan their crypto assets to Genesis in exchange for Genesis’ promise to pay a high interest rate.

    Gemini deducted agent fees that were as high as 4.29%, the SEC alleges.

    “Genesis then exercised its discretion in how to use investors’ crypto assets to generate revenue and pay interest to Gemini Earn investors,” the SEC said.

    By November, however, Genesis announced it would not allow the Gemini Earn investors to withdraw their crypto assets because of a liquidity crunch following volatility in the crypto market after FTX’s bankruptcy filing, the SEC said.

    At the time, Genesis held about $900 million in investor assets from 340,000 Gemini Earn investors, the SEC said. Gemini ended the Gemini Earn program earlier this month.

    “As of today, the Gemini Earn retail investors have still not been able to withdraw their crypto assets,” the SEC said in a statement.

    “We allege that Genesis and Gemini offered unregistered securities to the public, bypassing disclosure requirements designed to protect investors,” SEC Chair Gary Gensler said in a statement.

    The charges “build on previous actions to make clear to the marketplace and the investing public that crypto-lending platforms and other intermediaries need to comply with our time-tested securities laws,” Gensler said.

    The SEC’s complaint was filed in the U.S. District Court for the Southern District of New York.

    [ad_2]

    Source link

  • Federal Reserve – MarketWatch

    Federal Reserve – MarketWatch

    [ad_1]

    St. Louis Fed’s Bullard calls latest inflation data ‘encouraging’

    [ad_2]

    Source link

  • COVID subvariant dominant in northeastern U.S. has a growth advantage and may have greater ability to evade immunity than earlier strains, WHO says

    COVID subvariant dominant in northeastern U.S. has a growth advantage and may have greater ability to evade immunity than earlier strains, WHO says

    [ad_1]

    The XBB.1.5 omicron subvariant has a growth advantage over other circulating subvariants of the virus that causes COVID-19, and early data suggest it also has a greater ability to evade immunity than previous ones, according to the World Health Organization.

    In its weekly epidemiological update, the agency said the immune-escape data is based on preliminary lab-based studies and not on research in humans.

    “At present, there is no available information on clinical severity for XBB.1.5,” the WHO said. Data from the U.S. Centers for Disease Control and Prevention are showing that XBB.1.5 has become dominant in the northeastern U.S.

    Six omicron variants are currently being monitored, and they accounted for 76.2% of sequences submitted to a central database in the week through Dec. 25, the update said. The BQ.1 subvariant accounted for 53.4% of those.

    The global case tally fell 9%, to 2.9 million new cases, in the week through Jan. 8, although with testing and delays in reporting from some countries result due to the end-of-year holidays, those numbers should be treated with caution, said the WHO.

    The number of fatalities reported was down 125, to over 11,000.

    In the U.S., the seven-day average of new cases stood at 63,088 on Wednesday, according to a New York Times tracker. That’s down 2% from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    The daily average for hospitalizations was up 12% to 46,278. The average for deaths, meanwhile, was 555, which is up 61% from two weeks ago.

    Cases are now rising in 28 states, led by Florida, where they are up 90% from two weeks ago. On a per capita basis, New Jersey has the highest rate, at 32 new cases per 100,000 residents, followed by North Carolina, Rhode Island and South Carolina.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Travelers whose package tours were affected by the imposition of COVID-19 restrictions may be entitled to at least a partial refund, the European Union’s highest court said Thursday, the Associated Press reported. The European Court of Justice weighed in after being asked for its opinion by a court in Germany. The Munich court is considering the case of two people who bought a two-week package vacation on the Spanish island of Gran Canaria that started on March 13, 2020, just as the pandemic hit Europe. They are seeking a 70% refund because of restrictions that were imposed there two days later and their early return home.

    • People in China worried on Thursday about spreading COVID to elderly relatives as they planned visits to their hometowns for a holiday travel season that the WHO warns could inflame a raging outbreak, Reuters reported. The Lunar New Year holiday, which starts on Jan. 21, comes a month after China abandoned a strict zero-COVID regime of mass lockdowns that prompted widespread frustration and boiled over into historic protests. The outbreak, which is spreading from China’s megacities to rural areas that have weaker medical resources, is overwhelming some hospitals and crematoriums. The WHO on Wednesday said it would be challenging to manage the virus over a holiday period that is considered the world’s largest annual migration of people.

    Tens of thousands of people have resumed travels in and out of China after the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Photo: Tyrone Siu/Reuters

    • A 14th Mississippi child has died from COVID, the state’s department of health said Wednesday, the AP reported. The infant under the age of one was the first person under age 18 to die from COVID-19 in the state in 2023. According to state department of health data, eight children between the ages of 11 and 17 have died since the first cases of the virus were identified in 2020, making that age range the most prone to pediatric deaths in the state so far.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 665.8 million on Thursday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.5 million cases and 1,098,512 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.3 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 48.2 million Americans, equal to 15.4% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link

  • China stops issuing visas to Japanese and South Korean visitors as spat over test mandates for Chinese tourists widens

    China stops issuing visas to Japanese and South Korean visitors as spat over test mandates for Chinese tourists widens

    [ad_1]

    China stopped issuing visas for visitors from Japan and South Korea on Tuesday in apparent retaliation for COVID-testing measures imposed on travelers from China, the Associated Press reported. 

    China had warned it would take action against countries that mandate testing for its citizens, who are now free to travel after the government lifted strict restrictions on movement last month, unleashing a wave of new cases.

    At least 10 countries in Europe, North America and Asia have imposed test requirements recently, with officials expressing concern about a lack of information about the Chinese outbreak and the potential for new virus variants to emerge.

    Japan and South Korea protested the visa stoppage, the AP reported separately on Wednesday.

    South Korean Foreign Minister Park Jin said he finds it “significantly regrettable” that China stopped issuing short-term visas to South Koreans and called for China to align its pandemic steps with “scientific and objective facts.”

    Japanese Chief Cabinet Secretary Hirokazu Matsuno criticized China for “one-sidedly” restricting visa issuances to Japanese nationals “because of a reason that is not related to COVID-19 measures.”

    Tens of thousands of people have resumed travel in and out of China after the country lifted almost all of its border restrictions, ending three years of strict pandemic controls. Photo: Tyrone Siu/Reuters

    In the U.S., the seven-day average of new cases stood at 63,982 on Tuesday, according to a New York Times tracker. That’s down 4% from two weeks ago and below the recent peak of 70,508 on Christmas Eve.

    The daily average for hospitalizations was up 15% to 46,900. In an alarming statistic, the average for deaths stood at 580, up 50% from two weeks ago.

    Cases are currently rising in 22 states, as well as Guam, the U.S. Virgin Islands and Northern Mariana Islands. In Maryland, cases are up 170% from two weeks ago.

    On a per capita basis, New Jersey and Rhode Island are showing the highest rates, with New Jersey recording 32 cases per 100,000 residents and Rhode Island 31.

    Cases are also high on a per capita basis in North Carolina and South Carolina, as well as Mississippi and Florida.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Cyprus has joined the list of countries mandating COVID testing for tourists from China, the AP reported. The health ministry said it was heeding the advice of the European Union’s executive arm in requiring passengers from China to submit results from a PCR test taken 48 hours before their departure. The ministry also recommended the use of protective face masks on all flights to and from Cyprus as well as in any areas where people gather in large numbers.

    • The Chinese air-travel regulator is preparing to allow airlines to fly more routes between China and the U.S. following the lifting of COVID travel restrictions, state TV reported Wednesday, as the AP reported. U.S. and Chinese airlines are among some 40 carriers that have submitted applications covering some 700 flights per week involving 34 countries, China Central Television reported on its website. It gave no timeline for when normal flights might resume.

    See also: Chinese COVID cases expected to peak at 3.7 million a day by Jan. 13, with daily deaths reaching 25,000: health-data company forecast

    • The Pentagon formally dropped its COVID-19 vaccination mandate Tuesday, but a new memo signed by Defense Secretary Lloyd Austin also gives commanders some discretion in how or whether to deploy troops who are not vaccinated, the AP reported. Austin’s memo has been widely anticipated since Dec. 23, when a new law gave him 30 days to rescind the mandate. The Defense Department had already stopped all related personnel actions, such as discharging service members who refused the shot. “The Department will continue to promote and encourage COVID-19 vaccination for all service members,” Austin said in the memo. “Vaccination enhances operational readiness and protects the force.”

    Getting the flu can increase the risk of getting a second infection, such as strep throat. The Wall Street Journal’s Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 665.3 million on Wednesday, while the death toll rose above 6.7 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 101.3 million cases and 1,097,660 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 229.3 million people living in the U.S., equal to 69.1% of the total population, are fully vaccinated, meaning they have had their primary shots.

    So far, just 48.2 million Americans, equal to 15.4% of the overall population, have had the updated COVID booster that targets both the original virus and the omicron variants.

    [ad_2]

    Source link